← back to search

Raghu Ganugula

Texas A&M University · US
Area of research
Nutrition and Dietetics · Molecular Medicine
Research interest
Research interests include Medicine, Pharmacology, Diabetes mellitus, Chemistry, Inflammation, and Insulin.
h-index
citations
180
works
17
NIH funding
primary concept
email

Recent publications

Dual-function polyester nanoparticles for amplified anti-inflammatory effects
Science Advances 2025cited by 4position: middledoi
UPLC-MS/MS Method for Simultaneous Quantification of Cyclosporine A and Urolithin A in Plasma and Interspecies Analysis Across Mammals Including Humans
ACS Omega 2025cited by 1position: middledoi
Lymph node-targeted cyclosporine A alleviates myocarditis in lupus mice by inhibiting CD68 + macrophage-driven lymphangiogenesis
Materials Today 2025cited by 1position: firstdoi
Design and In Vitro Evaluation of Gambogic Acid-Conjugated Stearic Acid Solid Lipid Nanoparticles for Transferrin Receptor-Mediated Drug Delivery
Pharmaceutical Research 2025cited by 1position: firstdoi
Urolithin A-laden functional nanoparticles alleviate cisplatin-induced cardiotoxicity in mice by inhibiting inflammation-induced lymphangiogenesis
Free Radical Biology and Medicine 2025cited by 1position: middledoi
Engineered urolithin A-laden functional polymer-lipid hybrid nanoparticles prevent cisplatin-induced proximal tubular injury in vitro
European Journal of Pharmaceutics and Biopharmaceutics 2024cited by 11position: middledoi
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein
ACS Nano 2024cited by 10position: middledoi
Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies
Pharmacological Reviews 2024cited by 7position: middledoi
Lymph node targeting of cyclosporine ameliorates ocular manifestations in a mouse model of systemic lupus erythematosus (SLE) via PD-L1
Nano Today 2024cited by 6position: firstdoi
Systemic Anti-Inflammatory Therapy Aided by Curcumin-Laden Double-Headed Nanoparticles Combined with Injectable Long-Acting Insulin in a Rodent Model of Diabetes Eye Disease
ACS Nano 2023cited by 48position: firstdoi
Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin
ACS Applied Materials & Interfaces 2023cited by 12position: middledoi
Glucose-Responsive Microgel Comprising Conventional Insulin and Curcumin-Laden Nanoparticles: a Potential Combination for Diabetes Management
The AAPS Journal 2023cited by 8position: middledoi
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes
Pharmacological Reviews 2023cited by 4position: middledoi
Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis
Journal of Controlled Release 2022cited by 29position: firstdoi
Oral Nanocurcumin Alone or in Combination with Insulin Alleviates STZ-Induced Diabetic Neuropathy in Rats
Molecular Pharmaceutics 2022cited by 17position: middledoi
Paclitaxel and Urolithin A Prevent Histamine-Induced Neurovascular Breakdown Alike, in an <i>Ex Vivo</i> Rat Eye Model
ACS Chemical Neuroscience 2022cited by 4position: lastdoi
Nanoparticles that do not compete with endogenous ligands – Molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans
Journal of Controlled Release 2021cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

M. N. V. Ravi Kumar · University of Alabama at Birmingham17 papers (2021–2025)Meenakshi Arora · Texas A&M University15 papers (2021–2025) · 6 papers (2023–2025)Rita Basu · University of Virginia3 papers (2022–2024)Nikhil K. Nuthalapati · Georgetown University3 papers (2022–2025) · 3 papers (2023–2024)Erin M. Scott · Cornell University3 papers (2021–2023) · 3 papers (2022–2023)Dianxiong Zou · Texas A&M University3 papers (2021–2022)Dhaval K. Shah · New York University2 papers (2021–2024) · 2 papers (2025–2025)Sandeep K. Agarwal · Baylor College of Medicine2 papers (2023–2024)David Sheikh‐Hamad · Michael E. DeBakey VA Medical Center2 papers (2022–2025)Richard Friend · QIMR Berghofer Medical Research Institute2 papers (2022–2022) · 1 papers (2023–2023)Darshan S. Chandrashekar · University of Alabama at Birmingham1 papers (2023–2023)Rashmita Basu · University of Alabama at Birmingham1 papers (2024–2024)Anuhya Gottipati · University of Kentucky1 papers (2022–2022)Elisabetta Esposito · University of Ferrara1 papers (2024–2024) · 1 papers (2024–2024)